Processes for treating an individual to improve the functioning of the upper gastrointestinal tract including the esophagus and stomach, to treat an individual to proliferate the upper gastrointestinal tract tissue, to identify peptides usable to treat inflammatory conditions, to identify peptides, usable to prevent or improve inflammatory conditions, usable to identify peptides capable of proliferating upper gastrointestinal tract tissue, to prophylactically treat an individual, to improve the growth of upper gastrointestinal tract tissue in a mammal, and to treat an individual to improve the functioning of the gastrointestinal tract upper, kit, processes to promote the growth of upper gastrointestinal tract tissue or cells, to treat a patient to restore the upper gastrointestinal tract, to determine the activity of a hormone when used in combination with glp-2, to treat to have an individual having peptide ulcers

摘要

"PROCESSES TO TREAT AN INDIVIDUAL TO IMPROVE THE FUNCTIONING OF THE UPPER GASTROINTESTINAL TRACT INCLUDING THE SHAFUS AND STOMACH, TO TREAT AN INDIVIDUAL TO PROLIFY THE UPPER GASTROINTESTINAL TREATMENT, TO IDENTIFY PEPTIDATE ITEMS TO TREAT IT. OR IMPROVE INFLAMMATORY CONDITIONS, USABLE TO IDENTIFY PEPTIDE CAPABLE OF PROLIFERING TISSUE IN THE UPPER GASTROINTESTINAL TRACT, TO PROPHILATICALLY TREAT AN INDIVIDUAL, TO IMPROVE THE GROWTH OF THE GASTROINTESTING TREATMENT INTO A GASTROINTESTINAL TREATMENT TO GET A MORE TREATMENT OF TREATMENT SUPERIOR GASTROINTESTINAL, KIT, PROCESSES TO PROMOTE THE GROWTH OF TISSUE GROWTH OF THE SUPERIOR GASTROINTESTINAL TRACT OR CELLS, TO TREAT A PATIENT TO RESTORE THE SUPERIOR GASTROINTESTINAL TRACT, TO DETERMINE THE ACTIVITY OF A HORMONE WHEN USED IN COMBINATION, WITH 2 COMPINATION WITH COMBINATION TIE UP AN INDIVIDUAL HAVING PEPTIDIC ULCERS ". The invention relates to glucagon-related peptides and their use for the prevention or treatment of disorders involving the upper gastrointestinal tract including the esophagus and the stomach. In particular, it has now been shown that GLP-2 and GLP-2 peptide agonists can cause tissue proliferation in the upper gastrointestinal tract. Thus, the invention provides processes of proliferation of the upper gastrointestinal tract in an individual in need of it. In addition, the processes of the invention are usable to treat or prevent inflammatory conditions of the upper gastrointestinal tract, including inflammatory diseases, GLP-2 stimulates the growth of upper gastrointestinal tissue when administered in conjunction with other peptide hormones. The invention further provides pharmaceutical compositions of GLP-2 with at least one other peptide hormone, processes for improving the growth of upper gastrointestinal tissue and gastrointestinal disorders by increasing serum levels of GLP-2 and at least one other peptide hormone. , and a kit to carry out the processes of the invention.